Edition:
India

People: DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

16.47USD
25 Sep 2020
Change (% chg)

$0.70 (+4.44%)
Prev Close
$15.77
Open
$15.75
Day's High
$16.56
Day's Low
$15.75
Volume
10,211
Avg. Vol
50,285
52-wk High
$22.34
52-wk Low
$3.03

Raphael, Erez 

Mr. Erez Raphael serves as Chief Executive Officer, Director of the Company. Mr. Raphael served as Chairman of the Board of Directors from November 2014 to July 2018, and as a director from November 2014 to the present. He previously and until October 2012 served as our Vice President of Research and Development. Mr. Raphael has over 17 years of industry experience, having been responsible in his career for product delivery, technology and business development. Prior to joining us, from 2010 to 2012, Mr. Raphael served as Head of Business Operations for Nokia Siemens Networks, where he was responsible for establishing and implementing a new portfolio business unit directed towards marketing and sales of complimentary products. Prior to that, from 1998 to 2010, he held increasingly senior positions at Amdocs Limited (Nasdaq:DOX) where he was ultimately responsible for advising the Chief Technology Officer and implementing matters of overall business strategy. Mr. Raphael holds a B.A. in economics and business management from Haifa University. We believe Mr. Raphael is qualified to serve on our Board of Directors because of his extensive experience with technology companies and in sales and marketing.

Basic Compensation

Total Annual Compensation, USD 610,258
Restricted Stock Award, USD 660,819
Long-Term Incentive Plans, USD --
All Other, USD 111,120
Fiscal Year Total, USD 1,382,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Yoav Shaked

--

Richard Anderson

--

Erez Raphael

1,382,200

Zvi Ben-David

295,594

Dror Bacher

317,366

Olivier Jarry

280,945
As Of  31 Dec 2019